Wilson’s disease is a rare genetic condition that mainly requires lifelong copper chelation treatment. One of the most commonly used chelators for Wilson’s disease is Trientine hydrochloride capsule. In recent years, demand for Trientine in India has increased because of better awareness, diagnosis, and long-term disease management requirements.
This has led numerous patients, hospitals, caregivers, and healthcare providers to ask an important question:
Over the years, access to Trientine in India was limited and generally dependent on imports. However, this has significantly changed. Now, Trientine is available in India as a generic product, making treatment much more accessible and affordable for patients and their families.
Ikris Pharma Network has launched its own generic brand, Triokris (Trientine Hydrochloride 250 mg capsules) in India. The generic formulation is developed and manufactured at USFDA-approved manufacturing units. This manufacturing practice ensures regulatory compliance, high quality, and uninterrupted supply of generic Trientine for long-term Wilson’s disease management.